LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.056667
 80.31 27.76 5979 6976 0.8571 0.9617
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 82.01 27.76 249 7000 0.0356 0.3165
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 82.01 27.76 6433 7000 0.9190 0.9789
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 82.01 27.76 2948 7000 0.4211 0.7945
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 82.01 27.76 6014 7000 0.8591 0.9623
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 83.72 27.76 202 7055 0.0286 0.2820
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 83.72 27.76 6572 7055 0.9315 0.9823
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 83.72 27.76 2606 7055 0.3694 0.7656
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 83.72 27.76 6124 7055 0.8680 0.9649
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 85.42 27.76 246 7025 0.0350 0.3143
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 85.42 27.76 6717 7025 0.9561 0.9888
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 85.42 27.76 2526 7025 0.3595 0.7595
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 85.42 27.76 6217 7025 0.8849 0.9696
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 87.13 27.76 250 6987 0.0358 0.3173
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 87.13 27.76 6873 6987 0.9836 0.9959
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 87.13 27.76 2107 6987 0.3015 0.7209
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 87.13 27.76 6337 6987 0.9069 0.9756
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 88.84 27.76 244 6965 0.0350 0.3135
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 88.84 27.76 7014 6965 1.0070 1.0018
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 88.84 27.76 1492 6965 0.2142 0.6485
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 88.84 27.76 6374 6965 0.9152 0.9779
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 90.55 27.76 259 6928 0.0374 0.3237
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 90.55 27.76 7170 6928 1.0348 1.0086
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 90.55 27.76 827 6928 0.1194 0.5315
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 90.55 27.76 6492 6928 0.9370 0.9837
MN20160318_Q01
E11